WASHINGTON (dpa-AFX) - Alnylam Pharmaceuticals Inc. (ALNY) announced its preliminary fourth quarter 2022 global net product revenues for ONPATTRO, AMVUTTRA,…
WASHINGTON (dpa-AFX) - Alnylam Pharmaceuticals, Inc. (ALNY) Wednesday announced the submission of Clinical Trial Authorization or CTA application to Health…